.
OSMT financial statements
* Numbers in thousands
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
Capitalization * |
361 305 | 355 051 | 261 817 | 69 692 |
EV * |
559 047 | 527 136 | 367 329 | 367 329 |
Stock price $ |
7.98 | 6.78 | 4.17 | 1.11 |
Number of shares * |
45 276 | 52 367 | 62 786 | 62 786 |
EPS |
-2,42 | -5,17 | -1,27 | -1,27 |
Revenue * |
263 701 | 240 031 | 177 884 | 177 884 |
Net income * |
-109 396 | -270 901 | -79 589 | -79 589 |
Operating profit * |
5 683 | 3 052 | 1 747 | 1 747 |
Total liabilities * |
409 376 | 348 547 | 277 093 | 277 093 |
Net debt * |
197 743 | 177 434 | 105 512 | 105 512 |
Total assets * |
795 645 | 463 255 | 370 949 | 370 949 |
Equity * |
386 269 | 114 708 | 93 856 | 93 856 |
Cash and investments * |
70 834 | 95 865 | 114 053 | 114 053 |
Over the past 10 years, the maximum capitalization of Osmotica Pharmaceuticals plc is 361 305, the minimum is 261 817. Maximum net income 0, Minimum net income -270 901. The maximum price of OSMT shares is 7.98, the minimum price is 4.17.
.
OSMT valuation
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
P/E |
-3,30 | -1,31 | -3,29 | -0,88 |
P/B |
0,94 | 3,10 | 2,79 | 0,74 |
P/S |
1,37 | 1,48 | 1,47 | 0,39 |
E/P |
-30% | -76% | -30% | -114% |
P/FCF |
10,81 | 12,02 | 18,11 | 4,82 |
.
OSMT profitability
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
ROE |
-28% | -236% | -85% | |
ROA |
-54% | -130% | -39% | |
ROIC |
1% | 1% | 1% |